Nhận xét kết quả ghép tế bào gốc tạo máu đồng loài từ máu ngoại vi cho 21 trường hợp bệnh nhân máu tại Viện Huyết học và Truyền máu Trung ương từ 05/2008 - 03/2013

Allogeneic hematopoietic stem cell transplantation (Allo-HSCT) is aneffective treatment and and sometimes the only curative therapy for patients with certain hematological diseases. At the National Institute of Hematology and Blood Transfusion, Allo-HSCT from peripheral blood was carried out from from May 2008 to Mars 2013 to 21 cases in the process of Allo-HSCT accordance with the existing circumstances. The aim of this study to summarize the results and initial experiences of this treatment method. The results show: the success rate is 76 percent of the cases (16/21), should be noted that five cases of severe complications were seen in the early stage and at a later stage (from July 2011) there were 13 cases all live so far.